RT Book, Section A1 Raby, Benjamin A. A1 Tantisira, Kelan G. A2 Grippi, Michael A. A2 Antin-Ozerkis, Danielle E. A2 Dela Cruz, Charles S. A2 Kotloff, Robert M. A2 Kotton, Camille Nelson A2 Pack, Allan I. SR Print(0) ID 1194945826 T1 Personalized Pulmonary Medicine T2 Fishman’s Pulmonary Diseases and Disorders, 6e YR 2023 FD 2023 PB McGraw-Hill Education PP New York, NY SN 9781260473988 LK accessmedicine.mhmedical.com/content.aspx?aid=1194945826 RD 2024/04/25 AB Since the first draft sequences of the human genome were completed in 2001,1,2 medical research has increasingly focused on the utilization of genetic and genomic profiling in the prediction of disease susceptibility and natural history, as well as drug response and drug development. Personalized medicine, aka “precision” medicine, can be defined as an approach to medicine in which medical decisions are tailored to the individual patient. In theory, in patients with established disease, personalized medicine will make health care more efficacious, more affordable, and safer by avoiding costly and prolonged trial-and-error approaches, unwanted therapeutic side effects, and diminished treatment efficacy. In preclinical settings where an individual’s molecular profile could be used to estimate their risk of disease, precision medicine can be used to triage patients for more vigilant screening to identify disease presence before clinical indications and symptoms appear or to initiate preventative therapies. Thus, personalized medicine enhances the focus on preventive medicine at the primary, secondary, and tertiary levels. Fully realized, personalized medicine has the potential to facilitate early diagnosis and/or prevention of disease and selection of optimal therapeutic choices with minimal attendant side effects for established disease states. The potential benefits, from both a financial and quality of life perspective, are enormous.